Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Clinical trial NCT00621686 · COMPLETED
Trial details
- NCT number
- NCT00621686
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-10-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.